SCHEMBL14667995

SCHEMBL14667995

CCC(=O)Nc1cc2c(cc1C)nc1c(=O)[nH]c(=O)nc-1n2CCCc1ccc(C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.51
▸ KMT2A Q03164 6/20 0.51
▸ MAPT P10636 5/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ USP2 O75604 4/20 0.51
▸ HTT P42858 3/20 0.51
▸ TDP1 Q9NUW8 3/20 0.51
▸ RXFP1 Q9HBX9 2/20 0.51
▸ IDO1 P14902 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MITF O75030 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HAT1 O14929 4/20 0.43
▸ RBBP7 Q16576 4/20 0.43
▸ RECQL P46063 3/20 0.43
▸ CASP1 P29466 2/20 0.43
▸ BRCA1 P38398 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2556554 0.93 MEN1 (0.49) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL14668000 0.91 MEN1 (0.55) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL14667996 0.89 MEN1 (0.50) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL12287007 0.86 KMT2A (0.61) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL14668001 0.86 KDM4E (0.47) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL14667969 0.84 MEN1 (0.52) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL12287082 0.84 MEN1 (0.53) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL12286885 0.83 MEN1 (0.50) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL14668006 0.82 MEN1 (0.52) MEN1KMT2AMAPTKDM4EUSP2
SCHEMBL12287526 0.82 MEN1 (0.52) MEN1KMT2AMAPTKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130029980-A1 FLAVIN DERIVATIVES COISH PHILIP D G (US) 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029980-A1 FLAVIN DERIVATIVES BLVRB, FLAD1, FDPS MEN1 4701/4885KMT2A 3363/4885MAPT 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback